Reagents

Reagents are the operational currency of medicinal chemistry, enabling the systematic construction, functionalisation, and diversification of drug-like molecules across every stage of the drug discovery process. A reagent's practical utility in a medicinal chemistry campaign is governed not only by its reactivity but by a broader set of criteria: commercial availability, functional group tolerance, predictable chemoselectivity, operational simplicity, compatibility with parallel synthesis platforms, and the ability to deliver consistent results on milligram to gram scales under laboratory conditions. Analyses of the published medicinal chemistry output of major pharmaceutical companies, most notably the landmark 2011 study by Roughley and Jordan examining the combined output of GlaxoSmithKline, Pfizer, and AstraZeneca, and its 2016 update, have established that the majority of reactions in drug discovery programmes are performed with a relatively small core set of transformations and their associated reagents. Amide bond formation accounts for approximately 16% of all reactions in medicinal chemistry, making it the single most frequently executed transformation and reflecting the centrality of the amide bond to both bioactive scaffolds and synthetic linkers. Reductive amination, N-arylation, nucleophilic aromatic substitution (SNAr), N-substitution with alkyl halides, Suzuki-Miyaura coupling, and heterocycle formation together account for a further substantial proportion of reactions, collectively defining the practical boundary of what is routinely delivered in a hit-to-lead or lead optimisation campaign. Protection and deprotection chemistry, including Boc installation and removal, carboxylic acid ester hydrolysis, and other functional group masking strategies, are also among the most frequently performed operations, reflecting the iterative build-and-cleave logic of multi-step medicinal chemistry synthesis. The reagents enabling these reactions, coupling agents, reducing agents, oxidants, electrophilic functionalisation reagents, and building blocks, form the essential toolkit that underpins the entire enterprise.

Amide Bond Formation

Amide coupling is not a single reaction but an entire family of activating strategies, each supported by specific reagent systems. Uronium-based coupling reagents HATU (O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate) and HBTU are among the most widely used, activating carboxylic acids towards aminolysis under mild conditions in the presence of a tertiary amine base such as DIPEA or NMM. EDCI (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride), frequently used in combination with HOBt (1-hydroxybenzotriazole) or HOAt (1-hydroxy-7-azabenzotriazole) as an additive to suppress racemisation and improve coupling efficiency, is preferred for acid-sensitive substrates. T3P (propylphosphonic anhydride) is valued for its robustness and ease of aqueous workup. Carboxylic acids can also be activated as acyl chlorides using oxalyl chloride or thionyl chloride, providing highly reactive acylating agents for use with less nucleophilic amines, though with reduced functional group tolerance. For large-scale or process-scale amide coupling, Yamaguchi conditions using 2,4,6-trichlorobenzoyl chloride and DMAP are employed for hindered or macrolactonisation substrates.

Reductive Amination

Reductive amination involves the condensation of a primary or secondary amine with an aldehyde or ketone to form a transient imine or iminium ion, which is then selectively reduced to the amine. Sodium triacetoxyborohydride (NaBH(OAc)3) is the most widely used reductant, offering high chemoselectivity for the protonated imine over the carbonyl compound under mildly acidic conditions. Sodium cyanoborohydride (NaBH3CN) is an alternative with similar selectivity. For substrates where direct imine formation is slow, molecular sieves or titanium(IV) isopropoxide can be employed as Lewis acid activators to accelerate imine formation.

N-Arylation and Cross-Coupling Reactions

The Buchwald-Hartwig amination, using palladium precatalysts with biarylphosphine ligands such as RuPhos, XPhos, SPhos, and BrettPhos, enables C-N bond formation between aryl halides (including challenging aryl chlorides) and primary or secondary amines. Copper-catalysed Chan-Lam coupling between arylboronic acids and amines using Cu(OAc)2 and a base provides a complementary metal catalyst platform for C-N bond formation under aerobic conditions. The Suzuki-Miyaura coupling employs arylboronic acids or their pinacol esters with aryl or vinyl halides in the presence of a palladium catalyst and a base, typically K2CO3 or K3PO4. Organoboron substrates for these couplings are most efficiently prepared using bis(pinacolato)diboron (B2pin2) as the key borylating reagent, via the palladium-catalysed Miyaura borylation from aryl halides or through iridium-catalysed C-H borylation with Ir(COD)(OMe)]2/dtbpy catalyst systems.

Protecting Group Reagents

Boc (tert-butoxycarbonyl) protection of amines, installed using di-tert-butyl dicarbonate (Boc2O) in the presence of a base, followed by removal with trifluoroacetic acid (TFA) or HCl in dioxane, is the most prevalent protecting group strategy in medicinal chemistry. Cbz (benzyloxycarbonyl) protection with benzyl chloroformate and deprotection by hydrogenolysis using Pd/C under H2 provides an orthogonal option. PMB (para-methoxybenzyl) protection of alcohols and amines using PMB-Cl and a base, removed by DDQ (2,3-dichloro-5,6-dicyano-1,4-benzoquinone) oxidative cleavage or TFA, is also common. Silyl ethers, most commonly TBS (tert-butyldimethylsilyl) or TMS, protect alcohols using TBSCl or TMSCl with a hindered amine base, removed by fluoride sources such as TBAF.

Oxidation and Reduction Reagents

Dess-Martin periodinane (DMP) is the workhorse oxidant for converting primary and secondary alcohols to aldehydes and ketones in medicinal chemistry settings, prized for its chemoselectivity, mild conditions, and tolerance of sensitive functional groups. The Swern oxidation (DMSO/oxalyl chloride) and IBX (2-iodoxybenzoic acid) provide alternatives at larger scale or for substrates incompatible with DMP. Sodium borohydride (NaBH4) is used for reduction of ketones and aldehydes to alcohols; lithium aluminium hydride (LiAlH4) for reduction of esters, amides, and carboxylic acids; and diisobutylaluminium hydride (DIBAL-H) for controlled partial reduction of esters to aldehydes or carboxylic acids to alcohols at low temperature.

Electrophilic Functionalisation Reagents

Introduction of fluorine-containing groups is a high-priority operation in medicinal chemistry. Diethylaminosulfur trifluoride (DAST) and Deoxofluor convert alcohols and carbonyl groups to their geminal difluoride or monofluoro analogues. N-Fluorobenzenesulfonimide (NFSI) and Selectfluor (ACCUFLUOR NFTh) serve as bench-stable electrophilic fluorinating agents for enolates and electron-rich arenes. The Togni reagent (1-trifluoromethyl-1,2-benziodoxol-3(1H)-one) is a widely used electrophilic trifluoromethylating agent for nucleophiles and transition-metal catalysis. Sulfonyl chlorides serve as electrophilic partners for N-sulfonylation of amines, among the most common C-heteroatom bond-forming operations in medicinal chemistry.

Key Reagents for Building Block Synthesis

Bis(pinacolato)diboron (B2pin2, B2pin2) is perhaps the single most strategically important reagent for generating heteroaryl and aryl boronic ester building blocks used in Suzuki-Miyaura couplings and in SNAr-boronate strategies for library synthesis. It is moisture-stable and bench-stable, enabling palladium-catalysed Miyaura borylation of aryl halides to aryl-Bpin products, and can also be used in iridium-catalysed C-H borylation of heteroarenes, a reaction of particular value for installing boronate groups at positions inaccessible by halogenation. Trifluoroborate salts (ArBF3K), prepared from arylboronic esters by treatment with KHF2, are stable, crystalline building blocks for Suzuki coupling that are significantly more moisture-resistant than free boronic acids and particularly valued in parallel synthesis. Lawesson's reagent (2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide) converts carbonyl groups including amides, esters, and ketones to their thio analogues, providing direct access to thioamide and thiolactam building blocks. Zincke's salt (N-(2,4-dinitrophenyl)pyridinium chloride) and related electrophilic N-activation reagents enable ring-opening and re-functionalisation of pyridine rings. Burgess reagent (methyl N-(triethylammoniosulfonyl)carbamate) enables dehydration of beta-hydroxy amides to oxazolines and of amides to nitriles. Mander's reagent (methyl cyanoformate) is used for carboxymethylation of enolates to install methyl ester handles on carbocyclic and heterocyclic scaffolds.

Our catalogue of synthetic reagents spans all of these functional areas, from coupling agents and reducing agents through to building block synthesis reagents, providing the full toolkit required for efficient medicinal chemistry and drug discovery programmes.